Busca un médico

Emily B. Wolf, M.D.

  1. Hematologist

Publicaciones

  1. Wolf E, Melody M, Tsalatsanis A, Khatib SE, Vanegas YM, Velez-Tirado A, Rahman ZA, Gococo-Benore D, Eglinger B, Murthy H, Ayala E, Iqbal M, Parrondo R, Ailawadhi S, Badar T, Kumar A, Foran J, Roy V, Kharfan-Dabaja MA. Prognostic factors for early mortality following allogeneic hematopoietic cell transplantation in hematologic malignancies. Transplant Cell Ther. 2026 Aug 7 Epub 2026 Aug 07
    View PubMed
  2. Aslam FN, Vergara-Sanchez C, Tayon K, Wolf E, Howick V JF, Parikh P, Pollak P, Ray J, Ritchie C, Reddy P. A Rare Manifestation of Cardiac Myeloid Sarcoma. JACC Case Rep. 2026 Feb 18; 31(7):106240. Epub 2026 Jan 14.
    View PubMed
  3. Morecroft R, Lateef A, Parker JB, Sauls R, Phillipps J, Chipi P, Wolf E, Rivera C, Bourgeois K, Wang B, Majithia V, Mumtaz S. T-Cell Lymphoma With Sarcoid-Like Reaction and Secondary Myelofibrosis: A Unique Case Report and Literature Review. Case Rep Hematol. 2026; 2026:6857208 Epub 2026 June 23
    View PubMed
  4. Decosma L, Wolf E, Parent EE, Tun HW. Reversal of Cerebral Glucose Hypometabolism in a Patient with COVID and Refractory B-Cell Lymphoma. Int Med Case Rep J. 2026; 19:603559 Epub 2026 June 03
    View PubMed
  5. Shair K, Wolf E, Zaver H, Bali A, McCormick B, Call J, Grega J, Gibson T, Cowdell JC, El Sabbagh A, Hedges M. Novel Innovation Curriculum in Internal Medicine Residency Training. South Med J. 2025 Aug; 118 (8):561-565
    View PubMed
  6. Emily Wolf, Ewa Wysokinska, Surbhi Shah. Pomalidomide: A Step on the PATH Forward for Treatment of Hereditary Hemorrhagic Telangiectasia. The Hematologist. 2025.
  7. Wolf E, Sacchi de Camargo Correia G, Li S, Zhao Y, Manochakian R, Lou Y. Emerging Immunotherapies for Advanced Non-Small-Cell Lung Cancer. Vaccines (Basel). 2025 Jan 27; 13 (2)
    View PubMed
  8. Seby R, McCormick BJ, Wolf E, Kuhlman J, Jhawar N, Oman SP, Kase AM, Christenson C, Shaikh M. Respiratory Syncytial Virus Vaccine Induced Thrombotic Microangiopathy. J Blood Med. 2025; 16:331-335 Epub 2025 July 22
    View PubMed
  9. Plante MM, Wolf EB, Chirila RM. What are the management considerations for venous thromboembolic events in patients with cirrhosis? Cleve Clin J Med. 2024 Feb 2; 91 (2):86-88 Epub 2024 Feb 02
    View PubMed
  10. Nawaz N, Mistretta T, Karime C, Lewis J, Wolf E. Cholestatic Drug-Induced Liver Injury in a Patient Taking High-Dose Niacin for Hyperlipidemia. J Investig Med High Impact Case Rep. 2024 Jan-Dec; 12:23247096231224349
    View PubMed
  11. McKinley BJ, Pai TS, Wolf EB, Li S, Correia GSC, Zhao Y, Manochakian R, Lou Y. Early discontinuation of immune checkpoint inhibitor therapy prior to disease progression in patients with metastatic non-small cell lung cancer: a survival analysis. Front Oncol. 2024; 14:1417175 Epub 2024 June 21
    View PubMed
  12. Wolf EB, Imperial R, Jiang L, Agarwal AK, Tun HW. Clinical and Genomic Profile of Primary Cranial Neurolymphomatosis. J Blood Med. 2024; 15:291-303 Epub 2024 June 24
    View PubMed
  13. Wolf EB, Plante M, Chirila RM. If a patient has cirrhosis, should I correct coagulation abnormalities before a minor invasive procedure? Cleve Clin J Med. 2023 Sep 1; 90 (9):541-543 Epub 2023 Sept 01
    View PubMed
  14. Butts E, Gococo-Benore D, Pai T, Moustafa MA, Heng F, Chen R, Zhao Y, Manochakian R, Lou Y. Brief report: risk stratification following curative therapy for stage I NSCLC. Front Oncol. 2023; 13:1250315. Epub 2023 Aug 14.
    View PubMed
  15. Wolf EB, Li D, Fernandez AJ, Gardner LB, Rivera CE, Wysokinska EM, Shaikh ME, Tun HW, Roy V, Alhaj Moustafa M. Acquired Factor VII Deficiency Associated With Chronic Myeloid Leukemia Blast Crisis. J Investig Med High Impact Case Rep. 2023 Jan-Dec; 11:23247096231209543.
    View PubMed
  16. Gao RW, Day CN, Yu NY, Bush A, Amundson AC, Prodduturvar P, Majeed U, Butts E, Oliver T, Schwecke AJ, Moffett JN, Routman DM, Breen WG, Potter AL, Rivera-Concepcion J, Hoppe BS, Schild SE, Sio TT, Lou Y, Ernani V, Ko S, Olivier KR, Merrell KW, Garces YI, Manochakian R, Harmsen WS, Leventakos K, Owen D. Dosimetric predictors of pneumonitis in locally advanced non-small cell lung cancer patients treated with chemoradiation followed by durvalumab. Lung Cancer. 2022 Aug; 170:58-64 Epub 2022 June 13
    View PubMed
  17. Butts EB, Bui A, Chirila RM. 28-Year-Old Man With Joint Pain. Mayo Clin Proc. 2022 Jun; 97 (6):1188-1193
    View PubMed
  18. Bui A, Butts EB, Aslam N. 47-Year-Old Woman With Bilateral Flank Pain. Mayo Clin Proc. 2021 Dec; 96 (12):3147-3152
    View PubMed
  19. Butts Emily, Melody Megan, Turcano Pierpaolo, Kimbrough ErinMarie. Central neurogenic hyperventilation in an adult with multisystem Langerhans cell histiocytosis Interdisciplinary Neurosurgery. 2021; 26.
  20. Melody M, Butts E, Menke D, Landolfo K, Oken K, Sher T, Khurana S. Use of Tocilizumab in Management of Post-Operative Myelomonocytic Leukemoid Reaction. Leuk Res Rep. 2020; 14:100228 Epub 2020 Nov 04
    View PubMed
  21. Gobin E, Bagwell K, Wagner J, Mysona D, Sandirasegarane S, Smith N, Bai S, Sharma A, Schleifer R, She JX. A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential. BMC Cancer. 2019 Jun 14; 19 (1):581 Epub 2019 June 14
    View PubMed
  22. Butts E, Padala SA, Vakiti A, Kota V. Rectovaginal Fistula as a Complication of Fecal Management System. J Investig Med High Impact Case Rep. 2019 Jan-Dec; 7:2324709619869368
    View PubMed
  23. Allen AB, Butts EB, Copland IB, Stevens HY, Guldberg RE. Human platelet lysate supplementation of mesenchymal stromal cell delivery: issues of xenogenicity and species variability. J Tissue Eng Regen Med. 2017 Oct; 11 (10):2876-2884 Epub 2016 June 24
    View PubMed
PST-20604486